Table 5. Global annual cystic echinococcosis–associated economic losses to humans.
Region | Total adjusted economic losses (95% CI)*(US $) | Total adjusted economic losses (95% CI)† (US $) |
---|---|---|
Western Europe, USA, Canada, Australia, New Zealand | $309,983,585 ($244,256,327–$383,371,741) | $354,460,281 ($277,178,852–$440,438,597) |
Middle Eastern Crescent | $197,276,106 ($158,870,204–$240,282,181) | $564,496,304 ($454,402,304–$690,682,060) |
Formerly socialist economies of Europe and Russia | $46,896,902 ($37,750,210–$57,355,873) | $143,921,865 ($114,323,294–$176,555,114) |
China | $146,129,578 ($114,279,187–$181,937,463) | $663,712,150 ($516,048,103–$826,353,341) |
Other Asia and Islands | $1,535,990 ($1,159,946–$1,946,632) | $2,412,386 ($1,826,342–$3,074,240) |
Sub-Saharan Africa | $832,295 ($649,915–$1,035,681) | $5,176,229 ($3,710,869–$6,969,680) |
Latin America and the Caribbean | $48,396,449 ($38,408,001–$59,672,173) | $120,717,047 ($95,789,339–$148,939,896) |
India | $12,930,073 ($9,674,489–$16,499,072) | $63,422,693 ($47,576,673–$80,430,630) |
World | $763,980,979 ($676,048,731–$857,982,275) | $1,918,318,955 ($1,700,574,632–$2,142,268,992) |
*Income losses based on per capita gross national income (GNI) (Atlas method); CI, confidence interval. †Income losses based on purchasing power parity–adjusted per capita GNI.